Search - tctmd.com

Presenter: Dimitri Karmpaliotis, Tesfaldet Michael, Emmanouil Brilakis, Aristotelis Papayannis, Daniel Tran, Ben Kirkland, Nicholas Lembo, Kalynych Anna, Harold Carlson, Subhash Banerjee, William Lombardi, David Kandzari

January 31, 2013

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

Presentation TCT 2012

A Clinician's Perspectives

Presenter: David Kandzari

October 25, 2012

News Industry News

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

Presentation TCT 2012

Complex Lesions: Bifurcations and CTOs

Presenter: David Kandzari

October 23, 2012

Presentation TCT 2012

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Presenter: David Kandzari

October 22, 2012

Presentation TCT 2012

Left Main Bifurcation Stenting: Highlights from the Last 12 Months

Presenter: David Kandzari

October 22, 2012

Advertisement

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

An Evidence- and Practice-Based Rationale for Transradial Coronary Intervention

PCI for Chronic Total Occlusions: Rationale and Techniques

REMEDEE发布消息：‘二联疗法’支架通过早期疗效及安全性测试

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

REMEDEE Publicado: El Stente de ‘Tratamiento Doble’ Aprueba, sin Problemas, los Tests de Seguridad y Eficacia

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

Left Main Percutaneous Revascularization: Perspective on Advances in Method, Outcome and Clinical Decision Making

Coronary Chronic Total Occlusion Revascularization: Immediate Procedural Outcomes from a Multicenter US Registry

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

A Clinician's Perspectives

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Complex Lesions: Bifurcations and CTOs

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Left Main Bifurcation Stenting: Highlights from the Last 12 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content